Toyo Suisan Pink Sheet Forecast - Relative Strength Index

TSUKFDelisted Stock  USD 42.22  0.00  0.00%   
Toyo Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Toyo Suisan's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Toyo Suisan Kaisha has current Relative Strength Index of 79.36.
Check Toyo Suisan VolatilityBacktest Toyo SuisanInformation Ratio  

Toyo Suisan Trading Date Momentum

On November 23 2024 Toyo Suisan Kaisha was traded for  42.22  at the closing time. The highest daily price throughout the period was 42.22  and the lowest price was  42.22 . There was no trading activity during the period 0.0. Lack of trading volume on 11/23/2024 did not result in any price rise and fall. The trading price change to current closing price is 0.00% .
Compare Toyo Suisan to competition

View Toyo Suisan Related Equities

 Risk & Return  Correlation

Toyo Suisan Market Strength Events

Market strength indicators help investors to evaluate how Toyo Suisan pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Toyo Suisan shares will generate the highest return on investment. By undertsting and applying Toyo Suisan pink sheet market strength indicators, traders can identify Toyo Suisan Kaisha entry and exit signals to maximize returns.

Toyo Suisan Risk Indicators

The analysis of Toyo Suisan's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Toyo Suisan's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting toyo pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in Toyo Pink Sheet

If you are still planning to invest in Toyo Suisan Kaisha check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Toyo Suisan's history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements